ITM2B and early-onset autosomal dominant Alzheimer disease: Bri2 BRICHOS has been shown to prevent amyloid fibril formation from IAPP and Aβ in vitro [48, 49] and i.v. injections of BRICHOS reduced the amyloid load and gliosis in an mouse model of Alzheimer’s disease [50].